Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

Brain Section Multitasks, Handling Phonetics And Decision-Making
A front portion of the brain that handles tasks like decision-making also helps decipher different phonetic sounds, according to new Brown University research.
generic viagra online
Allergan Receives FDA Approval For ACUVAIL(TM) Ophthalmic Solution For The Treatment Of Pain And Inflammation Following Cataract Surgery
Allergan, Inc. (NYSE: AGN) announced that the United States Food and Drug Administration (FDA) has approved ACUVAIL(TM) (ketorolac tromethamine ophthalmic solution) 0.45%, an advanced, preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain and inflammation following cataract surgery. Cataracts are a leading cause of blindness among older adults and cataract surgery is the most frequently performed surgical procedure in the United States, with more than 3 million procedures performed each year.1
News of the day
Heatwave Advice For Diabetics
Experts are predicting record-breaking temperatures this week, so it"s important to take precautions to ensure that your diabetes remains well-controlled in this extreme weather.
Mental Health

Member Support Helps Breakthrough In Decriminalisation Of Dispensing Errors Campaign

The Royal Pharmaceutical Society"s campaign to change the unjust law which automatically criminalises any dispensing error has reached a significant milestone after the Department of Health announced plans to amend the Medicines Act 1968 at the earliest opportunity. The Society has been working with several Government departments and the Medicines and Healthcare Regulatory Agency (MHRA) to raise awareness of the current legislation that sets pharmacists apart from other healthcare providers. Although this process may take two years to complete, in the immediate future, discussions will be held with the Crown Prosecution Service, to develop interim guidelines for all Crown Prosecution Officers to remove the possibility of inappropriate prosecution for dispensing errors. As part of its campaign the Society has lobbied senior figures in the three main political parties, spoken with civil servants, addressed the All-Party Pharmacy Group and tabled an Early Day Motion (EDM) in the House of Commons. The EDM has already been supported by over 80 MPs, making it one of the most successful this year. This was achieved by the Society supporting its members to lobby their MPs effectively. President Steve Churton said: "We are enormously grateful to all of our members who supported our campaign on behalf of the profession and our patients, and are pleased with the impact our campaign to lobby government has had. No pharmacist should have to endure prosecution for genuine human error. The open reporting of errors is an essential activity in improving patient safety. "It has been just as heartening to see the way in which the profession has united and worked together for something they believe in. "Listening to and acting on our members concerns, and having this type of influence at Government level as a result, is an example of how our Professional Leadership Body will represent its members and provide a strong voice for pharmacy with real impact. "We will be working the Department of Health and the Medicines and Healthcare Products Regulatory Agency to deliver a workable alternative to the existing law. We will also be keeping a close eye on developments with the Crown Prosecution Service to ensure that pharmacists are not subject to unnecessary prosecution while we wait for the Medicines Act 1968 to be amended." Royal Pharmaceutical Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009